Etravirine
Summary
Persistence. Etravirine is potentially persistent.
Bioaccumulation. Etravirine has low potential for bioaccumulation.
Toxicity. Etravirine has very high chronic toxicity.
Risk. The use of etravirine (sales data Sweden 2022) has been considered to result in insignificant environmental risk.
This summary information is based on fass.se and assessment reports.
Detailed information
Assessment report Intelence 2008
Assessment report for Intelence (etravirine), Doc.Ref.: EMEA/CHMP/43952/2008.
Hazard
Persistence: "Because etravirine is highly adsorbed on soil (Koc 16.614 L/kg) and not readily biodegradable (DT50 in soil 587 days), an additional sediment dweller test is currently being performed; the results from this study will be provided as post-approval commitment."
Bioaccumulation: No data.
Toxicity: "Zebra Fish in an early-life stage toxicity test was performed, and no toxic effects were noted."
Risk
PEC/PNEC soil = 0.000066 wich gives the risk insignificant.
Assessment report Intelence 2012
Assessment report for Intelence 15 November 2012, EMA/CHMP/546580/2012.
Hazard
Persistence: "The adsorption/desorption coefficients (Koc) for activated sludge and soils indicates that ETR is immobile and will remain preferably in soil."
Bioaccumulation: Log Pow = 3.4. BCF of 370.3 and 476.9 indicate that etravirine does not bioaccumulate in aquatic organisms.
Toxicity: No data.
Risk
"Concerning the aquatic fate and effect assessment (Phase II Tier A), the ratios PECsurfacewater/PNECwater and PECgroundwater/PNECgroundwater are below 1 and the ratio PECsurfacewater/PNECmicroorganisms is below 0.1. Consequently, no further testing in the aquatic compartment is necessary and it can be concluded that etravirine and/or its metabolites are unlikely to represent a risk to the aquatic environment."
Assessment report Intelence 2020
Assessment report for Intelence, type II variation, 26 March 2020, EMA/175628/2020.
Hazard
Persistence: No data.
Bioaccumulation: Log Pow = 3.4.
Toxicity: PNECgroundwater is based on the NOEC result of the acute toxicity test with Daphnia magna. However, data for the NOEC is not provided.
Risk
PECsurfacewater/PNECwater = 0.2 μg/L/0.49 μg/L= 0.41.
Fass environmental information
Fass environmental information for Intelence from Janssen-Cilag (retrieved on 2025-06-30).
Hazard
Persistence: "Etravirine is slowly degraded to form four minor degradation products in an aerobic transformation test in aquatic sediment systems (OECD 308). Consequently, etravirine is not considered as readily biodegradable. The medicine is considered as potentially persistent."
Bioaccumulation: Log Pow = 3.4. BCFlow dose = 370.3 and BCFhigh dose = 476.9.
Toxicity: There are data for 3 trophic levels, most sensitive algae NOEC 4.9 microg/L.
Risk
PEC/PNEC is based on sales data in Sweden in year 2022. PEC/PNEC = 0.0016205 which gives the risk insignificant.
References
- European Medicines Agency. European public assessment report (EPAR) for Intelence (etravirine), Doc.Ref.: EMEA/CHMP/43952/2008.
- European Medicines Agency. European public assessment report (EPAR) for Intelence 15 November 2012, EMA/CHMP/546580/2012.
- European Medicines Agency. European public assessment report (EPAR) or Intelence, 26 March 2020, EMA/175628/2020.
- Fass för vårdpersonal.
Author: Health and Medical Care Administration, Region Stockholm
